C15 (Pentadecanoic Acid)

C15 (Pentadecanoic Acid) is a 3.0–3.5/10 fit for people using metabolic health, liver detox, and cardiovascular as a measured experiment, not a belief-based staple. The best anchors are Sun et al. 2025, which reports prospective and meta-analytic biomarker evidence and observational, not yet a C15:0 supplement trial, and Steffen et al. 2026, which reports cautionary cardiovascular evidence: modest observational associations, no incident CVD association, and no Mendelian-randomization support. That gives C15 (Pentadecanoic Acid) a real signal, but the report should stay narrow because responder fit, baseline status, and outcome tracking drive the practical value. Use C15 (Pentadecanoic Acid) when the target is specific, measurable, and worth the tradeoff. Skip or stop C15 (Pentadecanoic Acid) when the expected symptom, lab, or performance marker stays flat.

✅ Best for: Adults who do not eat dairy fat, follow vegan or low-dairy diets, have measured low circulating C15:0, and want a structured 12-week experiment rather than a belief-based subscription. C15:0 may also interest researchers replicating Robinson 2024 pharmacokinetic findings or clinicians studying diet-plus-C15 NAFLD protocols after TANGO. The cleanest use case is objective: baseline labs, 200 mg/day, repeat lipid panel and liver markers, then keep or stop based on measured change.

❌ Avoid if: You already consume grass-fed butter, aged cheese, full-fat yogurt, or other dairy fat and tolerate it well. Avoid C15:0 if pregnancy, lactation, pediatric use, or near-term conception is relevant, because Wang 2024 raises unresolved developmental questions. Skip it if your supplement budget is limited and omega-3, vitamin D3 + K2, fiber, sleep, resistance training, and fatty-liver diet basics are not handled. Do not use C15:0 as a substitute for guideline-backed cardiovascular, diabetes, liver, or cognitive care.